Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alexa C. Klimchak, Lauren E. Sedita, Katherine L. Gooch & Daniel C. Malone. (2023) Assessing the impact of single or short-term administration on a therapy’s cost-effectiveness: a hypothetical disease-agnostic model. Journal of Medical Economics 26:1, pages 594-602.
Read now
Read now
Olga Pitsillidou, Panagiotis Petrou & M. J. Postma. (2023) Implementing a Managed Entry Agreement Framework in Cyprus. Expert Review of Pharmacoeconomics & Outcomes Research 23:8, pages 857-865.
Read now
Read now
Chris Joseph, Thomas I. Gunton & James Hoffele. (2020) Assessing the public interest in environmental assessment: lessons from cost-benefit analysis of an energy megaproject. Impact Assessment and Project Appraisal 38:5, pages 397-411.
Read now
Read now
Daniel C. Malone, Rebecca Dean, Ramesh Arjunji, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner & Omar Dabbous. (2019) Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients. Journal of Market Access & Health Policy 7:1.
Read now
Read now
Violeta I Pérez-Nueno. (2015) Using quantitative systems pharmacology for novel drug discovery. Expert Opinion on Drug Discovery 10:12, pages 1315-1331.
Read now
Read now
Mehraj BY Parouty, Daan GM Krooshof, Tjalke A Westra, Petros Pechlivanoglou & Maarten J Postma. (2013) Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 523-547.
Read now
Read now
Maarten J Postma, Tjalke A Westra, Sibilia Quilici & Nathalie Largeron. (2013) Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples. Expert Review of Vaccines 12:5, pages 555-565.
Read now
Read now
Articles from other publishers (5)
Jillian L. Glasser, Shyam A. Patel, Neill Y. Li, Ram A. Patel, Alan H. Daniels & Valentin Antoci. (2022) Understanding Health Economics in Joint Replacement Surgery. Orthopedics 45:4.
Crossref
Crossref
Shyam A. Patel, Christopher L. McDonald, Neill Y. Li, Jacob M. Babu, Alan H. Daniels & Jeffrey A. Rihn. (2021) Understanding Health Economics in Spine Surgery. JBJS Reviews 9:3.
Crossref
Crossref
Jürgen John, Florian Koerber & Mareike Schad. (2019) Differential discounting in the economic evaluation of healthcare programs. Cost Effectiveness and Resource Allocation 17:1.
Crossref
Crossref
Tim Colbourn, Anni-Maria Pulkki-Brännström, Bejoy Nambiar, Sungwook Kim, Austin Bondo, Lumbani Banda, Charles Makwenda, Neha Batura, Hassan Haghparast-Bidgoli, Rachael Hunter, Anthony Costello, Gianluca Baio & Jolene Skordis-Worrall. (2015) Cost-effectiveness and affordability of community mobilisation through women’s groups and quality improvement in health facilities (MaiKhanda trial) in Malawi. Cost Effectiveness and Resource Allocation 13:1.
Crossref
Crossref
M. B. Y. Parouty, H. H. Le, D. Krooshof & M. J. Postma. (2014) Differential Time Preferences for Money and Quality of Life. PharmacoEconomics 32:4, pages 411-419.
Crossref
Crossref